BoneMRI
BoneMRI is cloud software that reconstructs CT-like 3D bone images from a dedicated MRI scan, covering the cervical, thoracic and lumbar spine and the pelvic region for adults and adolescents, with no ionising radiation at all.
What is BoneMRI?
BoneMRI is image processing software published by MRIguidance B.V., a medical technology company based in Utrecht, the Netherlands. It takes a dedicated MRI acquisition and reconstructs a three-dimensional image whose bone contrast resembles that of a CT scan, including quantitative Hounsfield Unit values, without exposing patients or staff to ionising radiation. Because the source is an MRI examination, a single scan yields both bone and soft tissue, and the resulting series are intrinsically registered to one another. The reconstruction relies on deep learning. The model was trained and validated on real patient data collected through clinical studies spanning several hospitals, countries, scanner manufacturers, field strengths and patient populations. Coverage extends to the cervical, thoracic and lumbar spine and to the pelvic region, for adults and for adolescents aged twelve and over. A dedicated adolescent configuration addresses total spine and pelvic imaging where dose reduction matters most, and an optional Synthetic T1w output derives three distinct contrasts from one source acquisition. Operationally, BoneMRI is a cloud service rather than a workstation application. A gateway module, delivered as a Windows installer, sits inside the hospital network, removes protected health information and forwards the study to the vendor's cloud. Reconstruction is triggered automatically once source data reaches the PACS and typically completes in five to fifteen minutes, with results returned to the PACS for viewing in any DICOM-compatible software. The product works with Philips, Siemens and GE scanners at 1.5 T and 3 T, and can also be obtained through the Siemens Healthineers Digital Marketplace. The regulatory position is unusually well documented for a directory entry. BoneMRI is CE certified as a class IIa medical device under the EU Medical Device Regulation and cleared for the United States market via FDA 510(k). The manufacturer holds ISO 13485 for quality management and ISO 27001 for information security. The product carries UDI-DI 08720892675538, the BoneMRI name is a registered trademark in the US, UK and EU, and two United States patents are listed. Instructions for use and DICOM conformance statements are published as PDFs for every release, currently version 1.12. Limits are stated plainly: no acute settings, no tumour work, and reduced reliability near metal implants.
What it does
- Reconstruct a 3D CT-like bone image from a dedicated MRI acquisition, with no ionising radiation
- Deliver quantitative Hounsfield Unit contrast and geometrically accurate bone morphology
- Cover the cervical, thoracic and lumbar spine and the pelvic region in adults and adolescents
- Produce Synthetic T1w images, giving three distinct contrasts from a single source acquisition
- Stitch adjacent spinal regions into one continuous total-spine image
- De-identify studies inside the hospital network before any data reaches the cloud
- Return finished reconstructions automatically to the hospital PACS, typically in five to fifteen minutes
When to use BoneMRI / When not to
A quick filter to help you decide if BoneMRI is the right fit.
When to use BoneMRI
- Radiologists reporting spine and pelvic studies who want bone detail and soft tissue from one examination
- Orthopaedic and spine surgeons preparing surgical planning or image-guided navigation
- Paediatric and adolescent care teams treating scoliosis or hip dysplasia, where dose reduction matters most
- Rheumatologists following spondyloarthritis, erosions or avascular necrosis over repeated examinations
- Hospital imaging departments looking to remove a preparatory CT from an existing MRI pathway
When not to use BoneMRI
- Emergency and trauma teams: the vendor excludes use in acute settings because of reconstruction time
- Oncology teams: the instructions for use explicitly exclude diagnosis and monitoring of primary or metastatic tumours
- Paediatric care below the age of twelve, which falls outside the stated indication
- Sites imaging heavily instrumented anatomy, where metal signal voids cannot be reconstructed
- Individuals or small practices expecting a self-service tool: deployment requires a contract, a gateway install and hospital IT involvement
How to use BoneMRI
A typical end-to-end flow, from setup to results.
- Contact the vendor through the demo request form; there is no online sign-up or self-service trial
- Agree commercial terms and sign the Data Processing Agreement the vendor concludes with each customer
- Install the gateway module, supplied as a Windows installer, on hospital infrastructure
- Open outbound HTTPS access on port 443 to the vendor cloud domain and its subdomains
- Secure the gateway host, which may hold protected health information, with disk encryption and strict access control
- Configure the MRI protocol and name the DICOM series following the required BoneMRI naming convention
- Acquire the dedicated sequence on a supported Philips, Siemens or GE scanner at 1.5 T or 3 T
- Let the gateway de-identify the study and forward it automatically once data reaches the PACS
- Retrieve the reconstruction from the PACS after roughly five to fifteen minutes
- Read bone and soft tissue together, or export to surgical planning and navigation software
Pros & Cons
Pros
- Removes the ionising radiation of a bone CT, which is the clearest benefit for adolescents and repeat imaging
- One examination returns both bone and soft tissue, with series intrinsically registered together
- Regulatory status is strong and verifiable: class IIa CE marking under MDR, FDA 510(k), ISO 13485 and ISO 27001
- Fits an existing radiology workflow through PACS and DICOM, with no dedicated reading station
- Works across the three main MRI manufacturers at both 1.5 T and 3 T without extra hardware
- The algorithm is frozen after deployment, so behaviour is reproducible and does not drift silently
- Instructions for use and DICOM conformance statements are published and versioned back to release 1.1
Cons
- No price is published anywhere: no pricing page exists and no amount appears on the site
- No terms and conditions and no legal notice are published, so the contractual relationship is invisible
- Availability is limited to the EU, UK and US markets, with a Swiss registration; nothing is offered elsewhere
- Excluded from acute settings and from tumour diagnosis or monitoring by the vendor's own instructions
- Metal implants create signal voids that cannot be reconstructed into CT-like data
- Deployment is heavy: a gateway install, firewall changes and coordination with hospital IT
- The clinical cloud's hosting location is never disclosed, and the ISO certificates are only available on request
Pricing & Plans
No pricing is published. The site contains no pricing page and no monetary amount of any kind, and the only commercial call to action is a demo request form. BoneMRI is therefore sold on a quotation basis, and no free plan or free trial is announced or denied. Prospective customers must contact the vendor to obtain terms. In the United States a Medicare billing code (HCPCS G-Code) was obtained in 2025, which governs reimbursement of the examination and should not be read as a licence price.
Data, GDPR & hosting
A consolidated view of how BoneMRI handles your data.
GDPR overview
GDPR compliance is claimed explicitly. The FAQ states the product complies with HIPAA, EU GDPR and the UK Data Protection Act, and every page carries a footer reading CE, FDA, ISO 13485, GDPR and ISO 27001. A Data Protection Officer is appointed and reachable at dpo@mriguidance.com, with a thirty-day response commitment, and the Dutch supervisory authority is named for complaints. Access, rectification, erasure, restriction, objection and portability rights are all listed. As the publisher is established in the Netherlands, no Article 27 representative is required or designated. Two documents coexist and do not agree: a privacy policy dated 3 January 2025 promises processing inside the EEA only, while a template privacy statement dated 17 March 2026 lists a purpose headed selling or sharing data with a third party.
Who owns the data?
No terms and conditions are published, so ownership of the reconstructed images is never stated. What the site does establish is the processing chain: a gateway installed inside the hospital removes protected health information and pseudonymises the study before anything leaves the hospital network, keeping only the indirect identifiers needed for reconstruction. The vendor states that a Data Processing Agreement is signed with every customer, which is where the detailed terms are said to live. For website, newsletter and recruitment data, the privacy policy dated 3 January 2025 names MRIguidance B.V. as responsible under the GDPR and appoints a Data Protection Officer.
Reuse rights
The site publishes no terms and conditions, so there is no public statement on whether a customer may reuse outputs freely. On the vendor's own use of data, two points are explicit. First, the reconstruction service processes studies solely to generate BoneMRI and Synthetic T1w images, which are returned to the hospital PACS. Second, the algorithm is frozen at deployment: it does not change after validation or installation and does not learn from data acquired at a customer site. Historic training used real patient data gathered through clinical studies across several hospitals, countries, scanner vendors and field strengths, which is a distinct matter from any ongoing use of a customer's images.
Data retention & training
Hosting summary
Two different scopes must be kept apart. For website, newsletter and recruitment data, the privacy policy dated 3 January 2025 states that everything collected is processed within the European Economic Area only and is not shared outside it without explicit prior consent; a Data Processing Agreement with Google covers analytics, and full IP addresses are blocked. For clinical data, the picture is thinner. Protected health information is removed inside the hospital before anything is sent, and the gateway pseudonymises studies before they leave the hospital network, but the site never names the country, region or provider hosting the clinical cloud that performs the reconstruction. No subprocessor list is published for the product. The European Economic Area commitment found on the site should therefore not be read as a statement about where patient images are stored. The website itself resolves to an address in the Netherlands, which describes the marketing site only.
Where BoneMRI works
Country-level availability.
Available in
Things to keep in mind
Risks and trade-offs to weigh before adopting BoneMRI.
- Automation bias: reconstructions arrive in the PACS automatically, which can invite reading them as ground truth rather than as a derived, model-generated image
- A CT-like image is not a CT: the contrast is synthesised from MRI data, and treating the two as interchangeable outside the validated indications is a clinical risk
- The site's two privacy documents disagree, one promising EEA-only processing and no sharing without consent, the other listing a purpose about selling or sharing data with a third party
- The hosting location of the clinical cloud is never disclosed, so the jurisdiction that governs patient images cannot be verified from the site
- Ownership of the reconstructed images is nowhere addressed, because no terms and conditions are published
- Certifications and accreditations displayed by the hospitals, clinicians and scanner manufacturers referenced on the site belong to those third parties and say nothing about this product
- Skill erosion: routinely delegating bone assessment to a generated series may reduce familiarity with the underlying MRI signal it is derived from
Setup & Integrations
Technical difficulty
Moderate to high, and firmly an IT project rather than a sign-up. A gateway module supplied as a Windows installer must be deployed on hospital infrastructure, outbound HTTPS access opened to the vendor cloud, and the gateway host secured with disk encryption and strict access control because it can hold protected health information. MRI protocols and DICOM series naming must follow the vendor's convention, and localising a series name requires a vendor service engineer. Once in place, daily use is effortless: reconstruction is triggered automatically and needs no per-examination action.
Integrations
Behind BoneMRI
Fundraising
Social
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
What does BoneMRI actually produce?
Is BoneMRI an approved medical device?
Which anatomies and scanners are supported?
Which patients can be imaged?
How long does a reconstruction take?
How is it integrated into a hospital?
Are patient images used to train the algorithm?
What does it cost?
Where is BoneMRI available?
When should BoneMRI not be used?
Should you pick BoneMRI?
BoneMRI is a narrow, serious product with an unusually complete and checkable regulatory file. The promise is easy to state and hard to dismiss: obtain the bone detail of a CT from an MRI examination, and remove the ionising radiation along with the second appointment. For adolescent spine work, repeat follow-up and surgical planning, that is a substantive clinical argument rather than a marketing one, and the class IIa CE marking, the FDA 510(k) clearance, the published instructions for use and the versioned DICOM conformance statements all support it. The reservations are commercial and documentary rather than clinical. No price appears anywhere on the site, no terms and conditions are published, and the ISO certificates are only supplied on request, so a prospective buyer cannot assess the offer without entering a sales conversation. Deployment is not light either: a gateway must be installed inside the hospital, firewall rules opened and DICOM naming conventions respected, which makes hospital IT a necessary participant rather than an afterthought. Availability is also bounded, covering the EU, UK and US markets plus a Swiss registration, and the two privacy documents on the site do not tell the same story about sharing data with third parties. The vendor is refreshingly explicit about what the product must not do. It is excluded from acute settings and from tumour diagnosis and monitoring, it is limited to patients aged twelve and over, and it degrades near metal implants. Stating those limits plainly is a mark of confidence rather than weakness. Read as what it is — a regulated imaging component bought by a department, not a tool an individual signs up for — BoneMRI looks well built and honestly presented, provided the buyer accepts a quotation-based purchase and a genuine integration project.
- Choosing a selection results in a full page refresh.
- Opens in a new window.